PHK
CRBP icon

Point72 Hong Kong’s Corbus Pharmaceuticals CRBP Stock Holding History

Point72 Hong Kong’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-62
Closed -$4K – 1985
2021
Q1 		$4K Buy
+62
New +$4.08K ﹤0.01% 1665
2020
Q4 		– Sell
-20
Closed -$1K – 1773
2020
Q3 		$1K Sell
20
-33
-62% -$5.98K ﹤0.01% 1136
2020
Q2 		$13K Buy
+53
New +$10.7K ﹤0.01% 948

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Point72 Hong Kong's CRBP Position: Q2 2021 in Review

Point72 Hong Kong sold out of Corbus Pharmaceuticals (CRBP) in Q2 2021, closing a stake of 62 shares — an estimated $4K sold.

Point72 Hong Kong first reported a position in CRBP in Q2 2020 and held it in 3 quarters. The position peaked at $13K in Q2 2020. 98 funds tracked by Wall St. Rank hold CRBP as of Q2 2021.

  • Point72 Hong Kong reported no remaining Corbus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 62 Corbus Pharmaceuticals shares in Q2 2021, an estimated $4K.
  • Point72 Hong Kong first reported a position in Corbus Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Point72 Hong Kong's Corbus Pharmaceuticals position peaked at $13K in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.